HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Geriatric oncology field ‘entering into adulthood’ Jennifer R. Southall
-
- Should machine learning be used to assess clinical trial data on older adults with cancer?
- AACR report: Pandemic led to nearly 10 million missed cancer screenings in 7 months Ryan Lawrence
- Addition of darolutamide to ADT, docetaxel prolongs OS in metastatic prostate cancer Mark Leiser
- AI platform predicts thyroid cancer, pathologic stage, BRAF status using ultrasound images Devin McLaughlin
- American Cancer Society CEO delivers call to action on genitourinary cancer disparities Devin McLaughlin
- Axitinib-nivolumab combination demonstrates efficacy in metastatic renal cell carcinoma Mark Leiser
- BRCA mutations linked to increased risk for pancreatic, male breast, other cancers Ryan Lawrence
- Combination active in HER2-expressing urothelial carcinoma Mark Leiser
-
- Daily aspirin use fails to reduce risk for breast cancer recurrence Ryan Lawrence
- Immune-related adverse events after inhibitor use linked to benefit in urothelial cancer Devin McLaughlin
- Mid-treatment imaging guides radiation de-escalation in oropharynx cancer Mark Leiser
- Networking at medical conferences can be ‘so important’ for early-career oncologists Jennifer R. Southall
- Niraparib regimen ‘new first-line option’ for certain men with metastatic prostate cancer Mark Leiser
- Polygenic hazard score predicts risk for metastatic, fatal prostate cancer across groups Devin McLaughlin
- RFS an inadequate surrogate for OS after resection for colorectal liver metastasis Mark Leiser
- Social risk factors ‘heavily influence’ racial disparities in cancer surgical care Devin McLaughlin
-
- Some men with prostate cancer may benefit from continued enzalutamide after progression Devin McLaughlin
- Study shows paucity of surgical oncology trials Jennifer R. Southall
- Thyroidectomy without radioiodine noninferior for patients with low-risk thyroid cancer Jennifer R. Southall
- Tumor tissue modified viral-HPV DNA test predicts HPV-driven oropharynx cancer recurrence Ryan Lawrence
- Zebrafish could help researchers develop treatments for childhood cancers Jennifer Byrne; James Amatruda, MD, PhD
- Adjuvant pembrolizumab extends DFS for certain patients with non-small cell lung cancer Devin McLaughlin
- Momelotinib improves outcomes in pretreated myelofibrosis Mark Leiser
- Sugemalimab extends OS in stage IV non-small cell lung cancer Mark Leiser
-
- ASH announces 2022 Scholar Award recipients
- University of Utah Health appoints radiation oncology department chair
- Vanderbilt-Ingram Cancer Center director to assume new leadership role